These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7310225)

  • 1. Rapid in vivo clearance of C5ades arg: a possible protective mechanism against complement-mediated tissue injury.
    Weisdorf DJ; Hammerschmidt DE; Jacob HS; Craddock PR
    J Lab Clin Med; 1981 Dec; 98(6):823-30. PubMed ID: 7310225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.
    Movat HZ; Rettl C; Burrowes CE; Johnston MG
    Am J Pathol; 1984 May; 115(2):233-44. PubMed ID: 6326579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
    Perez HD; Chenoweth DE; Goldstein IM
    J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.
    Craddock PR; Hammerschmidt D; White JG; Dalmosso AP; Jacob HS
    J Clin Invest; 1977 Jul; 60(1):260-4. PubMed ID: 874088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo clearance and tissue distribution of C5a and C5a des arginine complement fragments in rabbits.
    Webster RO; Larsen GL; Henson PM
    J Clin Invest; 1982 Dec; 70(6):1177-83. PubMed ID: 7174788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A differential effect of C5a and C5a des Arg in the induction of pulmonary inflammation.
    Larsen GL; McCarthy K; Webster RO; Henson J; Henson PM
    Am J Pathol; 1980 Jul; 100(1):179-92. PubMed ID: 7395964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airways hyperreactivity and inflammation produced by aerosolization of human C5A des arg.
    Irvin CG; Berend N; Henson PM
    Am Rev Respir Dis; 1986 Oct; 134(4):777-83. PubMed ID: 3767132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin-induced shock in the rat. A role for C5a.
    Smedegård G; Cui LX; Hugli TE
    Am J Pathol; 1989 Sep; 135(3):489-97. PubMed ID: 2789475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A direct in vivo comparison of the inflammatory properties of human C5a and C5a des Arg in human skin.
    Swerlick RA; Yancey KB; Lawley TJ
    J Immunol; 1988 Apr; 140(7):2376-81. PubMed ID: 3351304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two endogenous neutrophil-activating peptides in psoriatic skin and inflammatory cells: C5ades arg and NAP.
    Christophers E; Schröder JM; Mrowietz U
    Dermatologica; 1989; 179 Suppl 1():9-15. PubMed ID: 2673857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation and the toxicity of stroma-free hemoglobin solutions in primates.
    Feola M; Simoni J; Dobke M; Canizaro PC
    Circ Shock; 1988 Aug; 25(4):275-90. PubMed ID: 3168173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dialyzer reuse on complement activation and neutropenia in hemodialysis.
    Stroncek DF; Keshaviah P; Craddock PR; Hammerschmidt DE
    J Lab Clin Med; 1984 Sep; 104(3):304-11. PubMed ID: 6470561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1H nuclear magnetic resonance assignments and secondary structure of porcine C5ades Arg.
    Williamson MP
    J Mol Biol; 1989 Mar; 206(2):407-10. PubMed ID: 2716054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo clearance studies of the terminal fluid-phase complement complex in rabbits.
    Hugo F; Berstecher C; Krämer S; Fassbender W; Bhakdi S
    Clin Exp Immunol; 1989 Jul; 77(1):112-6. PubMed ID: 2766574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales.
    Schröder JM; Christophers E
    J Invest Dermatol; 1986 Jul; 87(1):53-8. PubMed ID: 3014008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of human neutrophils to C5a: a role for the oligosaccharide moiety of human C5ades Arg-74 but not of C5a in biologic activity.
    Gerard C; Chenoweth DE; Hugli TE
    J Immunol; 1981 Nov; 127(5):1978-82. PubMed ID: 7299121
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of the chemotactic activity of human C5a des Arg by an anionic polypeptide ("cochemotaxin") in normal serum and plasma.
    Perez HD; Goldstein IM; Webster RO; Henson PM
    J Immunol; 1981 Feb; 126(2):800-4. PubMed ID: 7451994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway responses in vitro following C5a des Arg-induced hyper-responsiveness in vivo in rabbits.
    Armour CL; Black JL; Vincenc KS; Johnson PR; Ward H; Berend N
    Clin Exp Pharmacol Physiol; 1987 Jan; 14(1):7-14. PubMed ID: 3608241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of complement activation during membrane-based plasmapheresis procedures.
    Burnouf T; Eber M; Kientz D; Cazenave JP; Burkhardt T
    J Clin Apher; 2004; 19(3):142-7. PubMed ID: 15493055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.